Who do you rate?
Recommend a Supplier
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
CDMO MAP
Top 30 Pharma CDMO Countries in Europe 2025
Analysis of 552 CDMO manufacturing sites across Europe reveals the countries with the most facilities in operation.
Created in partnership with Fuliginous Management Consulting this infographic highlights the countries which have the most facilities in Europe who develop and manufacture Finished Dosage Forms (FDF) of small molecules.
The country with the most contract manufacturing facilities is France (1st), followed by Italy (2nd) and Spain (3rd). See the full ranking below.
Top 30 countries for European CDMO Facilities
The top 30 european countries for contract development and manufacturing of Finished Dosage Forms (FDF) of small molecules are as follows:
| Rank | Country | # Facilities |
| 1 | France | 84 |
| 2 | Italy | 78 |
| 3 | Germany | 75 |
| 4 | Spain | 54 |
| 5 | UK | 29 |
| 6 | Poland | 22 |
| 7 | Switzerland | 22 |
| 8 | Greece | 21 |
| 9 | Türkiye | 19 |
| 10 | Portugal | 17 |
| 11 | Sweden | 14 |
| 12 | Belgium | 12 |
| 13 | Ireland | 10 |
| 14 | Austria | 9 |
| 15 | Netherlands | 9 |
| 16 | Romania | 9 |
| 17 | Bulgaria | 8 |
| 18 | Czech Republic | 6 |
| 19 | Denmark | 5 |
| 20 | Malta | 5 |
| 21 | Estonia | 4 |
| 22 | Finland | 4 |
| 23 | Hungary | 4 |
| 24 | Latvia | 4 |
| 25 | Lithuania | 4 |
| 26 | Belarus | 3 |
| 27 | Israel | 3 |
| 28 | Norway | 3 |
| 29 | Slovakia | 3 |
| 30 | Ukraine | 3 |
“This ranking is the result of a combination of historical reasons. ” comments George Ntortas and Kyriakos Kansos, CDMO Consultants for Fuliginous Management Consulting.
Leading countries France (1st), Italy (2nd) and Germany (3rd) benefit from “a well-established pharmaceutical industry, regulatory compliance, skilled workforce, advanced infrastructure, innovation, proximity to markets, and government support” making them prime locations for pharmaceutical manufacturing in Europe.”
Over the last few decades, the trend towards contract manufacturing has been reinforced by pharma companies divesting a big number of manufacturing sites located in those countries.
“In addition we also see a trend within the industry towards specialising on sterile forms like sterile glass vials, lyophilization and pre-filled syringes, which are more specialised technologies compared to OSD and non-sterile liquids.”
“These specialised capabilities find a more appropriate environment in Central Europe and in countries like France and Germany compared to other regions of the continent.” says George.
Join us at CDMO Live 2025 (7-8th May, Rotterdam) for a full analysis of the changing European CDMO Landscape by Fuliginous. Find out more
Download the European CDMO Landscape 2025
Download a free high resolution infographic of European CDMOs (below) by filling out the short form.
Download the European CDMO Landscape 2025 infographic